AZU1 and Sepsis: Recently, NE was suggested as a biomarker for bacterial infection in patients with COPD (Thulborn et al., 2019) and increased levels of HBP secretion have been associated with sepsis (Herwald et al., 2004; Fisher and Linder, 2017).